1. How Moderna Execs are Cashing in on COVID-19 Vaccine Stock Speculation

    How Moderna Execs are Cashing in on COVID-19 Vaccine Stock Speculation

    (Reuters) - Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash. In the meantime, the firm’s chief executive is pocketing millions of dollars every month by selling shares that have tripled in price on news of Moderna’s development progress, a Reuters analysis of corporate filings shows...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. This may be their one shot at making a boatload of money if the vaccine doesn't work out.
  3. Topics Mentioned